Kathleen A. Rickard - 29 Aug 2025 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role: Chief Medical Officer
Signature: /s/ Andrew Fisher, Attorney-in-fact for Kathleen A. Rickard
Issuer symbol: VRNA
Transactions as of: 29 Aug 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Sep 2025, 16:30:53 UTC
Previous filing: 05 Aug 2025
Next filing: 08 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Rickard Kathleen A.	Chief Medical Officer	3 MORE LONDON RIVERSIDE, LONDON, UNITED KINGDOM	/s/ Andrew Fisher, Attorney-in-fact for Kathleen A. Rickard	03 Sep 2025	0001836883

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VRNA	Ordinary Shares	Gift	$0	-189,600	-7.3%	$0.000000	2,417,872	29 Aug 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2	Consists of (i) 647,480 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 80,935 ADSs); and (ii) 1,770,392 Ordinary Shares underlying 221,299 ADSs.